During the 1951-1957 period, vaccine research coalesced around adjuvant-enabled control of immune responses and the deployment of attenuated and oral vaccines to support mass immunization. Researchers established that immunologic adjuvants could boost antibody magnitude and steer duration, while investigations into antigen presentation clarified how different formulations shape protection. Attenuated and orally administered vaccines gained prominence, and findings on how prior exposure or imprinting influences responses reframed strategies for strain selection and immunization campaigns.